Journal Papers, Abstracts, and Commentaries
Breast Disorders
|
Breast Abscess
|
Journal Papers, Abstracts, and Commentaries
|
Gynecomastia |
Journal Papers, Abstracts, and Commentaries
Journal Papers, Abstracts, and Commentaries
Journal Papers, Abstracts, and Commentaries
Journal Papers, Abstracts, and Commentaries
| |
Neurological and Psychiatric Adverse Effects of
Antiretroviral Drugs.
Abers MS, Shandera WX, Kass JS
CNS Drugs.
2013 Dec 21.
Abstract
Risk of clinically significant depression in HIV-infected
patients: effect of antiretroviral drugs.
Gutiérrez F, García L, Padilla S, et al
HIV Med. 2013 Nov 11.
Abstract
Depression associated with antiretroviral drug therapy in HIV:
case report and overview.
Kaestner F, Anneken K, Mostert C,
et al
Int J STD AIDS. 2012
Jun;23(6):e14-9.
Abstract
Incidence, medical and socio-behavioural predictors of psychiatric
events in an 11-year follow-up of
HIV-infected patients on antiretroviral therapy.
Protopopescu C, Raffi F, Brunet-François C, et al
Antivir Ther.
2012 Apr 27.
Abstract
Psychiatric Risk Factors for HIV Disease Progression: The Role of
Inconsistent
Patterns of Antiretroviral Therapy Utilization.
Carrico AW,
Riley ED, Johnson MO, et al
J Acquir Immune Defic Syndr.
2010 Nov 24.
Abstract |
HIV-1-Associated Dementia During HAART Therapy.
Aquaro S, Svicher V, Ronga L, et al
Recent Patents CNS Drug Discov. 2008
Jan;3(1):23-33.
Abstract
|
Neuropsychiatric complications of antiretroviral therapy.
Cespedes MS, Aberg JA.
Drug Saf. 2006;29(10):865-74.
Abstract
Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular
Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue
Distribution.
van Wijk JP, Cabezas MC.
Int J Vasc Med.
2012;2012:201027.
Abstract
|
Journal Papers, Abstracts, and Commentaries
| |
Changes in Body Mass Index Following HAART Initiation among
HIV-Infected Women in the Women’s Interagency HIV Study.
Sharma A, Bynum SA, Schneider MF, et al
J AIDS Clin Res. 2014;5.
Abstract
FULL-TEXT ARTICLE
Systematic review of antiretroviral-associated lipodystrophy: lipoatrophy, but
not central fat gain, is an antiretroviral adverse drug reaction.
de Waal R, Cohen K, Maartens G.
PLoS One.
2013 May 28;8(5):e63623
Paper
Lipid profile of HIV-infected patients in relation to
antiretroviral therapy: a review.
Souza SJ, Luzia LA, Santos SS, Rondó PH.
Rev Assoc Med Bras. 2013
Mar-Apr;59(2):186-98.
Abstract
The development of metabolic risk factors after the initiation of the second
line anti- retroviral therapy.
Mittal A, Achappa B, Madi D, et al
J Clin Diagn Res. 2013
Feb;7(2):265-8.
Abstract |
Differences in body fat distribution assessed by ultrasonography
in patients receiving antiretroviral drugs.
Signorini DJ, Oliveira Netto AM,
Rev Assoc Med Bras.
2012 Apr;58(2):197-203.
Abstract
Effects of first antiretroviral regimen on lipid
levels in HIV (+) individuals.
Papadopoulos A, Pantazis N, Panagopoulos P, et al
J Chemother.
2012;24(1):38-47..|
Abstract
FULL-TEXT PDF ARTICLE
Dyslipidemia in HIV-infected women on antiretroviral therapy. Analysis of 922
patients from the
Spanish VACH cohort.
Estrada V, Geijo P, Fuentes-Ferrer M,
et al
BMC Womens Health. 2011 Aug 4;11(1):36
Paper
Switching antiretroviral therapy to minimize metabolic
complications.
Lake JE, Currier JS.
HIV Ther.
2010 Nov;4(6):693-711
Abstract
Pharmacogenetics of the Metabolic Disturbances and Atherosclerosis Associated
with
Antiretroviral Therapy in HIV-Infected Patients.
Veloso S, Peraire J, Viladés C, et al
Curr Pharm Des. 2010 Aug 5
Abstract
|
Lipotoxicity on the Basis of Metabolic Syndrome and
Lipodystrophy in HIV-1-Infected
Patients Under Antiretroviral Treatment.
Giralt M, Díaz-Delfín J, Gallego-Escuredo JM,
et al
Curr Pharm Des. 2010 Aug 5.
Abstract
|
Adipose Tissue as a Target of HIV-1 Antiretroviral Drugs. Potential
Consequences on
Metabolic Regulations.
Caron-Debarle M, Boccara F, Lagathu C, et al
Curr Pharm Des. 2010 Aug 5
Abstract
|
Contribution of Inflammation to Fat Redistribution and Metabolic Disturbances
in HIV-1
Infected Patients.
Stankov MV, Behrens GM.
Curr Pharm Des.
2010 Aug 5.
Abstract |
Drug-induced lipotoxicity: lipodystrophy associated with
HIV-1-infection and antiretroviral treatment.
Villarroya F, Domingo P, Giralt M.
Biochim Biophys Acta. 2009 Sep 29.
Abstract |
Alcohol and race/ethnicity elicit different changes in lipid
profiles in HIV-infected individuals
receiving highly active antiretroviral therapy.
Míguez-Burbano MJ, Lewis JE, Malow R.
J Assoc Nurses AIDS Care.
2009 May-Jun;20(3):176-83
Abstract
|
Metabolic outcomes in a randomized trial of nucleoside,
nonnucleoside and protease
inhibitor-sparing regimens for initial HIV treatment.
Haubrich RH, Riddler SA, Dirienzo AG, et al
AIDS.
2009 May 4.
Abstract |
The Effect of Individual Antiretroviral Drugs on Body Composition
in HIV-Infected Persons Initiating
Highly Active Antiretroviral Therapy.
Shlay JC, Sharma S, Peng G, et al
J Acquir Immune Defic Syndr.
2009 Apr 29
Abstract |
Human Immunodeficiency Virus and Highly Active Antiretroviral
Therapy-Associated Metabolic Disorders
and Risk Factors for Cardiovascular Disease.
Anuurad E, Semrad A, Berglund L.
Metab Syndr Relat Disord.
2009 Apr 8.
Abstract
|
|
Conference Reports, Abstracts, and Posters
|
| |
Impact of short-term change in body mass index (BMI) after
antiretroviral therapy (ART) initiation on subsequent risk
of cardiovascular disease (CVD) and diabetes in HIV-positive
individuals: the D:A:D study
A.C. Achhra, A. Mocroft, P. Reiss, et al
(XX International
AIDS Conference)
Abstract
Incidence rate and risk factors of diabetes mellitus in
HIV-1 infected adults on antiretroviral therapy (ART) in
Thailand,
P. Riyaten, N. Salvadori, R. Suaysod, et al
(XX International
AIDS Conference)
Abstract
Understanding lipodystrophy among men and women living with
HIV: a metasynthesis of qualitative research
M. Gagnon, L. Cormier
(XIX International
AIDS Conference)
Abstract
Hyperlactataemia is a common complication of antiretroviral
therapy in children in rural Mopani District, South Africa
M. van Ramshorst, H. Struthers, J.A. McIntyre R.P.H. Peters
(XIX International
AIDS Conference)
Abstract
Epidemiological aspect, clinical and psychosocial impact of
lipodystrophy related to antiretroviral drugs in people
living with HIV followed up at the center of care CRIPS-TOGO
in Lome
K.M. Aho, D. Idimama Kotoudi, A. Patassi, B. Saka
(XIX International
AIDS Conference)
Abstract |
Journal Papers, Abstracts, and Commentaries
|
Central and Peripheral Nervous
Systems |
| |
|
|
|
Journal Papers, Abstracts, and Commentaries
| |
Factors associated with neurocognitive test performance at baseline: a
substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START)
trial.
Wright E, Grund B, Cysique, et al
HIV Med.
2015 Apr;16 Suppl S1:97-108.
Abstract
Patterns of peripheral neuropathy in ART-naïve patients
initiating modern ART regimen.
Lee AJ, Bosch RJ, Evans SR, et al
J
Neurovirol. 2015 Feb 13.
Abstract
Plasma and cerebrospinal fluid biomarkers predict cerebral
injury in HIV-infected individuals on stable combination antiretroviral
therapy.
Anderson AM, Harezlak J, Bharti A. et al
J Acquir Immune Defic Syndr. 2015 Jan 23.
Abstract
Antiretroviral drugs induce oxidative stress
and neuronal damage in the central nervous system.
Akay C, Cooper M, Odeleye A, et al
J Neurovirol. 2014
Jan 14
Abstract
Neurological and Psychiatric Adverse Effects
of Antiretroviral Drugs.
Abers MS, Shandera WX, Kass JS
CNS Drugs.
2013 Dec 21.
Abstract
HIV-associated neurocognitive disorders:
Antiretroviral regimen, central nervous system penetration
effectiveness, and cognitive outcomes.
Cross HM, Combrinck MI, Joska JA.
S
Afr Med J.
2013 Sep 18;103(10):758-762.
Abstract
Persisting Inflammation and Chronic Immune
Activation but Intact Cognitive Function in HIV-infected
patients After Long Term Treatment with Combination
Antiretroviral Therapy.
Pedersen KK, Pedersen M, Gaardbo JC,
et
al
JAcquir Immune Defic Syndr.
2013 Feb .
Abstract |
The brain and potent ART: the final frontier?
Powderly W.
J Int AIDS Soc. 2012 Nov 11;15(6):18175
Abstract |
Prolonged treatment with boosted protease
inhibitor monotherapy is not associated with a higher rate
of neurocognitive impairment than triple drug ART.
Pérez-Valero I, González-Baeza A, Estébanez M, et al
JInt AIDS Soc. 2012 Nov
11;15(6):18179.
Abstract
Neurocognitive Impact of Antiretroviral Treatment: Thinking
Long-Term.
McPhail ME, Robertson KR.
Curr HIV/AIDS Rep.
2011 Aug 12
Abstract
Brain dysfunction in the era of combination antiretroviral
therapy: Implications
for the treatment of the aging population of HIV-infected
individuals.
Clark US, Cohen RA.
Curr Opin Investig Drugs.
2010 Aug;11(8):884-900
Abstract |
Incident
Neuropathy in HIV-Infected Patients on HAART.
Nakamoto BK, McMurtray A, Davis J, et al
AIDS Res Hum Retroviruses. 2010 Jul 12
Abstract |
Discordance Between Cerebral Spinal Fluid and Plasma HIV
Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral
Therapy.
Canestri A, Lescure FX, Jaureguiberry S, et al
Clin Infect Dis.
2010 Jan 25.
Abstract |
Evidence for ongoing brain injury in human immunodeficiency virus-positive
patients treated with antiretroviral
therapy.
Cardenas V, Meyerhoff D, Studholme C,
et al
J Neurovirol.
2009 Jun 4:1-10.
Abstract |
HAART is associated with lower hepatic necroinflammatory activity
in HIV-hepatitis C
virus-coinfected patients with CD4 cell count of more than 350
cells/microl at the time of
liver biopsy.
Pascual-Pareja JF, Caminoa A, Larrauri C, et al
AIDS. 2009
May 15;23(8):971-5
Abstract |
Cerebrovascular Ischemic Events in HIV-1-Infected Patients
Receiving Highly Active Antiretroviral
Therapy: Incidence and Risk Factors.
Corral I, Quereda C, Moreno A, et al
Cerebrovasc Dis.
2009 Apr 24;27(6):559-563.
Abstract |
Motor function and human immunodeficiency virus-associated cognitive
impairment in a highly
active antiretroviral
therapy-era cohort.
Robinson-Papp J, Byrd D, Mindt MR, et al
Arch Neurol. 2008
Aug;65(8):1096-101.
Abstract
|
Mitochondrial haplogroups and peripheral neuropathy during
antiretroviral therapy:an adult AIDS clinical trials group study.
Hulgan T, Haas DW, Haines JL, et al
AIDS. 2005 Sep
2;19(13):1341-1349.
Abstract
|
|
Conference Reports, Abstracts, and Posters |
| |
| |
High rates of
asymptomatic neurocognitive impairment (aNCI) in HIV-1 infected subjects
receiving
stable combination anti-retroviral therapy (CART) with undetectable plasma
HIV RNA
L. Garvey, D. Yerrakalva, A. Winston, et al
(5th IAS Conference)
Abstract |
Neurotoxic effect of
antiretroviral agents on CNS
Husstedt IW,
Reichelt D, Oelker-Grueneberg U, Evers
(Ninth International Congress on Drug Therapy in HIV Infection)
Abstract |
Journal Papers, Abstracts,
and Commentaries
Conference Reports, Abstracts, and Posters
|
| |
Oral lesions as clinical markers of HAART failure: a nested
case-control study
in Mexico City
Ramírez-Amador V., Anaya- Saavedra G,
Crabtree-Ramírez B, et al
(4th IAS Conference)
Abstract |
Journal Papers, Abstracts, and Commentaries
|
| |
FULL-TEXT ARTICLE
HIV-Antiretroviral Therapy Induced Liver, Gastrointestinal,
and Pancreatic Injury.
Neuman MG, Schneider M, Nanau RM, Parry C.
Int J Hepatol.
2012;2012:760706.
Paper
The role of antiretroviral therapy in the incidence of pancreatitis in
HIV-positive individuals
in the EuroSIDA study.
Smith CJ, Olsen CH, Mocroft A, et al
AIDS. 2008 Jan
2;22(1):47-56.
Abstract |
Conference Reports, Abstracts, and Posters
| |
Pancreatic toxicity revisited in the HAART era
R Manfredi, L Calza
(8th Int Congress on Drug Therapy in HIV Infection)
Abstract
|
|
|
HAART
Main Page